X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (14050) 14050
Newsletter (75) 75
Magazine Article (21) 21
Book Chapter (10) 10
Publication (7) 7
Newspaper Article (5) 5
Conference Proceeding (3) 3
Dissertation (3) 3
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (13051) 13051
female (9733) 9733
science & technology (9030) 9030
middle aged (8965) 8965
life sciences & biomedicine (8900) 8900
fluorouracil - administration & dosage (8640) 8640
male (8100) 8100
aged (7888) 7888
adult (6672) 6672
antineoplastic combined chemotherapy protocols - therapeutic use (6540) 6540
fluorouracil - adverse effects (6398) 6398
oncology (6345) 6345
antineoplastic combined chemotherapy protocols - adverse effects (5491) 5491
chemotherapy (3450) 3450
treatment outcome (3409) 3409
fluorouracil - therapeutic use (3338) 3338
cancer (2887) 2887
leucovorin - administration & dosage (2390) 2390
deoxycytidine - analogs & derivatives (2353) 2353
colorectal neoplasms - drug therapy (2278) 2278
fluorouracil (2167) 2167
cisplatin - administration & dosage (2149) 2149
antineoplastic combined chemotherapy protocols - administration & dosage (2124) 2124
fluorouracil - analogs & derivatives (2109) 2109
drug administration schedule (2096) 2096
capecitabine (2052) 2052
breast neoplasms - drug therapy (1988) 1988
aged, 80 and over (1916) 1916
disease-free survival (1732) 1732
5-fluorouracil (1717) 1717
colorectal cancer (1708) 1708
adenocarcinoma - drug therapy (1692) 1692
neoplasm staging (1681) 1681
deoxycytidine - administration & dosage (1644) 1644
combined modality therapy (1634) 1634
organoplatinum compounds - administration & dosage (1581) 1581
survival rate (1519) 1519
care and treatment (1508) 1508
antimetabolites, antineoplastic - adverse effects (1478) 1478
colorectal neoplasms - pathology (1353) 1353
retrospective studies (1350) 1350
chemotherapy, adjuvant (1346) 1346
pharmacology & pharmacy (1333) 1333
medicine & public health (1328) 1328
leucovorin - adverse effects (1314) 1314
survival analysis (1271) 1271
neoplasm metastasis (1262) 1262
deoxycytidine - adverse effects (1251) 1251
camptothecin - analogs & derivatives (1241) 1241
abridged index medicus (1178) 1178
follow-up studies (1161) 1161
antimetabolites, antineoplastic - administration & dosage (1136) 1136
research (1132) 1132
prognosis (1108) 1108
surgery (1096) 1096
antineoplastic agents - adverse effects (1085) 1085
cyclophosphamide - administration & dosage (1079) 1079
stomach neoplasms - drug therapy (1077) 1077
prospective studies (1043) 1043
antimetabolites, antineoplastic - therapeutic use (1042) 1042
infusions, intravenous (1041) 1041
organoplatinum compounds - adverse effects (1029) 1029
animals (1011) 1011
metastasis (982) 982
cisplatin - adverse effects (971) 971
dose-response relationship, drug (945) 945
camptothecin - administration & dosage (931) 931
liver neoplasms - drug therapy (900) 900
time factors (888) 888
colonic neoplasms - drug therapy (881) 881
antineoplastic agents - therapeutic use (871) 871
breast cancer (867) 867
carcinoma, squamous cell - drug therapy (862) 862
analysis (841) 841
liver neoplasms - secondary (837) 837
radiotherapy (836) 836
methotrexate - administration & dosage (828) 828
oxaliplatin (812) 812
breast neoplasms - pathology (809) 809
drug therapy (808) 808
antineoplastic agents - administration & dosage (782) 782
drug therapy, combination (760) 760
leucovorin - therapeutic use (758) 758
clinical trials (729) 729
deoxycytidine - therapeutic use (729) 729
doxorubicin - administration & dosage (729) 729
hematology, oncology and palliative medicine (727) 727
cyclophosphamide - adverse effects (708) 708
health aspects (704) 704
toxicity (704) 704
adenocarcinoma - pathology (680) 680
rectal neoplasms - drug therapy (668) 668
cisplatin (632) 632
kaplan-meier estimate (627) 627
bevacizumab (617) 617
disease progression (605) 605
pancreatic neoplasms - drug therapy (603) 603
taxoids - administration & dosage (601) 601
colorectal neoplasms - mortality (598) 598
clinical trials as topic (595) 595
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (13018) 13018
Japanese (679) 679
French (223) 223
German (221) 221
Chinese (183) 183
Russian (82) 82
Spanish (68) 68
Italian (56) 56
Portuguese (21) 21
Polish (18) 18
Dutch (13) 13
Danish (12) 12
Hungarian (12) 12
Hebrew (7) 7
Norwegian (7) 7
Korean (6) 6
Czech (5) 5
Swedish (5) 5
Slovak (3) 3
Turkish (3) 3
Bulgarian (2) 2
Finnish (2) 2
Romanian (2) 2
Ukrainian (2) 2
Lithuanian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Book Review
Journal of the National Comprehensive Cancer Network, ISSN 1540-1405, 07/2014, Volume 12, Issue 7, pp. 1028 - 1059
The NCCN Guidelines for Colon Cancer address diagnosis, pathologic staging, surgical management, perioperative treatment, posttreatment surveillance,... 
Life Sciences & Biomedicine | Oncology | Science & Technology | ras Proteins - genetics | Proto-Oncogene Proteins p21(ras) | Colonic Neoplasms - drug therapy | Humans | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Antineoplastic Agents - therapeutic use | Bevacizumab | Colonic Neoplasms - surgery | Fluorouracil - therapeutic use | Deoxycytidine - therapeutic use | Leucovorin - adverse effects | Fluorouracil - adverse effects | Antineoplastic Agents - adverse effects | Angiogenesis Inhibitors - therapeutic use | Deoxycytidine - adverse effects | Leucovorin - therapeutic use | Cetuximab | Liver Neoplasms - secondary | Angiogenesis Inhibitors - adverse effects | Camptothecin - analogs & derivatives | Antibodies, Monoclonal, Humanized - adverse effects | Camptothecin - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Camptothecin - therapeutic use | Fluorouracil - analogs & derivatives | Membrane Proteins - genetics | Liver Neoplasms - drug therapy | Liver Neoplasms - surgery | Proto-Oncogene Proteins - genetics | Treatment Outcome | Disease Progression | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | GTP Phosphohydrolases - genetics | Proto-Oncogene Proteins B-raf - genetics | Colonic Neoplasms - pathology | Organoplatinum Compounds - therapeutic use | Deoxycytidine - analogs & derivatives | Organoplatinum Compounds - adverse effects
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 06/2017, Volume 317, Issue 23, pp. 2392 - 2401
IMPORTANCE: Combining biologic monoclonal antibodies with chemotherapeutic cytotoxic drugs provides clinical benefit to patients with advanced or metastatic... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Leucovorin - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Bevacizumab - therapeutic use | United States | Bevacizumab - adverse effects | Colorectal Neoplasms - genetics | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Antineoplastic Agents - therapeutic use | Cetuximab - therapeutic use | Cetuximab - adverse effects | Organoplatinum Compounds - administration & dosage | Fluorouracil - administration & dosage | Leucovorin - adverse effects | Fluorouracil - adverse effects | Antineoplastic Agents - adverse effects | Colorectal Neoplasms - drug therapy | Aged, 80 and over | Angiogenesis Inhibitors - therapeutic use | Adult | Camptothecin - administration & dosage | Female | Angiogenesis Inhibitors - adverse effects | Camptothecin - analogs & derivatives | Colorectal Neoplasms - mortality | Camptothecin - adverse effects | Kaplan-Meier Estimate | Treatment Outcome | Canada | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Colorectal Neoplasms - secondary | Aged | Genes, ras | Organoplatinum Compounds - adverse effects | Chemotherapy | Usage | Care and treatment | Research | Colorectal cancer | Cancer | Drugs | Medical research | Colorectal carcinoma | Clinical trials | Cytotoxicity | Patients | Survival | K-Ras protein | Bevacizumab | Metastases | Survival analysis | Irinotecan | Oxaliplatin | Monoclonal antibodies | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 1533-4406, 10/2014, Volume 371, Issue 17, pp. 1609 - 1618
... and overall survival, with an increase in some side effects. 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Follow-Up Studies | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Bevacizumab | Fluorouracil - therapeutic use | Antibodies, Monoclonal, Humanized - administration & dosage | Leucovorin - adverse effects | Fluorouracil - adverse effects | Neoplasm Metastasis - drug therapy | Colorectal Neoplasms - drug therapy | Adult | Female | Leucovorin - therapeutic use | Liver Neoplasms - secondary | Camptothecin - analogs & derivatives | Colorectal Neoplasms - mortality | Antibodies, Monoclonal, Humanized - adverse effects | Camptothecin - adverse effects | Camptothecin - therapeutic use | Kaplan-Meier Estimate | Liver Neoplasms - drug therapy | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Colorectal Neoplasms - pathology | Organoplatinum Compounds - therapeutic use | Organoplatinum Compounds - adverse effects | Treatment outcome | Care and treatment | Analysis | Colorectal cancer | Dosage and administration | Leucovorin | Fluorouracil | Colorectal carcinoma | Diarrhea | Metastasis | Survival | Patients | Clinical outcomes | Metastases | Irinotecan | Stomatitis | Chemotherapy | Neurotoxicity | Oxaliplatin | Monoclonal antibodies | Vascular endothelial growth factor | Neutropenia | Index Medicus | Abridged Index Medicus
Journal Article
Annals of oncology, ISSN 0923-7534, 11/2009, Volume 20, Issue 11, pp. 1842 - 1847
Journal Article